Bayer to dump $2.26B into manufacturing realignment as it says goodbye to some sites
Bayer is ready to pour billions more into its pharma manufacturing operations, but with that, it will cut ties with several sites it already owns …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
